Physician
Hematology
Dr. John E. Godwin, MD
|
|
Give Review
Dr. John E. Godwin is an expert in the field of Hematology. He attended University of Alabama School of Medicine. University of Alabama School of Medicine has a rank of 37 in research and a 17 in primary care He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACP)" and "Whos Who in Medicine and Healthcare". John E. Godwin, MD is a published physician. He has 28 papers published. The most current publication "A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest onco..." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- A phase II trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with Acute myeloid leukemia.
- A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed Acute myeloid leukaemia.
- Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric/adult AML: a report from the Children's Oncology Group and SWOG.
- Histone deacetylase inhibitor romidepsin has differential activity in core binding factor Acute myeloid leukemia.
- Age and Acute myeloid leukemia.
- An unusual case of recurrent Loffler endomyocarditis of the aortic valve.
- Heparin-induced thrombocytopenia with associated Thrombosis in children after the Fontan operation: report of two cases.
- The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia.
- Thoracentesis: a safe procedure in mechanically ventilated patients.
- Nodal ALK positive anaplastic large cell Lymphoma of the axilla with spontaneous regression.
- Thromboembolism in cancer patients: pathogenesis and treatment.
- Takayasu's arteritis associated with factor V Leiden.
- Hypoplastic myelodysplastic Syndrome.
- Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis.
- Testing for Passovoy defect in children with prolonged activated partial thromboplastin time (APTT)
- ProMACE day 1/MOPP day 8 chemotherapy for prolymphocytic Leukemia: a case report of prolonged survival.
- Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic Syndrome.
- A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic Leukemia: a Southwest Oncology Group study.
- A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic Syndromes.
- Gene expression profiling of adult Acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.
- Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 Acute myeloid leukemia and high-risk myelodysplastic syndromes ...
- Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials.
- Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple Myeloma patients and cell lines.
- A phase I study of induction chemotherapy for older patients with newly diagnosed Acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC...
- Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in Acute myeloid leukemia by multiparameter flow cytometry: identificatio...
- A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated Acute myeloid leukemia: a Southwest onco...
- Acute myeloid leukemia in the older patient.
Schools
Univ Of Al Sch Of Med
Baylor College Of Med
Fell Baylor College Med
Nc Meml Hospital University Nc
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Choice Health PPO
- Connect
- PHCS Network PPO
- ODS Health Plan
- Preferred PSN
- Heritage Plus
- Heritage Signature
- Personal Option EPO
- Preferred PPO
- Preferred Provider Network PPN
- Choice Plus POS
- Options PPO
- PacifiCare HMO
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Whos Who in Medicine and Healthcare
Education
-
University of North Carolina Hospitals -
Baylor College of Medicine -
University of Alabama School of Medicine
Drug Facts
| NPI NUMBER | 1700863677 | |
| NPPES Provider LastName | GODWIN | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 972132933 | |
| NPPES Provider State | OR | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 231.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700863677 |
| Last Name Of The Provider | GODWIN |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Robert C. Lufkin, DO |
|
|
Dr. Gina Vaccaro, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kim-Hien T. Dao, DO |
|
|
Dr. Brian J. Druker, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael C. Heinrich, MD |
|
|
Dr. Anthony J. Melaragno, MD |
|
|
Dr. Yaping Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine L. Lin, MD |
|
Dr. Regan M. Look, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ted L. Huang, MD |
|
|
Dr. Fred R. Sullivan Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nina M. Lamble, MD |
|
|
Dr. Michael B. Belzer, MD |
|
|
Dr. Josy Mathew, MD
This Doctor is OpenDoctor Recommended.
|